S Rubinchik
Impact in
- Genetics top 10%
- Virus-based gene therapy research
- Bacterial Genetics and Biotechnology
-
- RNA Interference and Gene Delivery
- Sphingolipid Metabolism and Signaling
- Cell death mechanisms and regulation
- RNA and protein synthesis mechanisms
- Viral Infectious Diseases and Gene Expression in Insects
Papers in
-
- RNA Interference and Gene Delivery 6
- Viral Infectious Diseases and Gene Expression in Insects 3
- Sphingolipid Metabolism and Signaling 2
- RNA and protein synthesis mechanisms 2
- Peroxisome Proliferator-Activated Receptors 1
- Genetics 7
- Virus-based gene therapy research 4
- Bacterial Genetics and Biotechnology 3
- Co-authors
- Marvin Gold (3 shared papers)Wendy Parris (3 shared papers)Stephen Lowe (3 shared papers)James S. Norris (3 shared papers)Tsuyoshi Honda (1 shared paper)Jian Dong (2 shared papers)Alicja Bielawska (2 shared papers)Mahvash Tavassoli (2 shared papers)
- Journals
- Gene Therapy (5 papers)Journal of Biological Chemistry (3 papers)Cancer Gene Therapy (1 paper)Current Gene Therapy (1 paper)Molecular Therapy (1 paper)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
S Rubinchik
13 papers receiving 374 citations
Peers
Comparison fields: 5 of 46
- Genetics 170
- Molecular Biology 289
- Ecology 75
- Biotechnology 20
- Oncology 55
Countries citing papers authored by S Rubinchik
This map shows the geographic impact of S Rubinchik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S Rubinchik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S Rubinchik more than expected).
Fields of papers citing papers by S Rubinchik
This network shows the impact of papers produced by S Rubinchik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S Rubinchik. The network helps show where S Rubinchik may publish in the future.
Co-authors
The 25 scholars most cited alongside S Rubinchik, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 62 | |
| 2 | 2006 | 56 | |
| 3 | 2006 | 50 | |
| 4 | 2000 | 45 | |
| 5 | 1994 | 33 | |
| 6 | 2001 | 27 | |
| 7 | 1994 | 25 | |
| 8 | 1994 | 25 | |
| 9 | 2001 | 24 | |
| 10 | 2005 | 12 | |
| 11 | The 72-kilodalton IE-1 protein of human cytomegalovirus (HCMV) is a potent inducer of connective tissue growth factor (CTGF) in human dermal fibroblasts. | 2004 | 12 |
| 12 | 2004 | 6 | |
| 13 | Human papillomavirus and head and neck cancer: a growing concern. | 2008 | 5 |
About S Rubinchik
S Rubinchik is a scholar working on Molecular Biology, Genetics, Ecology, Oncology and Surgery, having authored 13 papers that have together received 382 indexed citations. Recurring topics across this work include RNA Interference and Gene Delivery (6 papers), Virus-based gene therapy research (4 papers), Viral Infectious Diseases and Gene Expression in Insects (3 papers), Bacterial Genetics and Biotechnology (3 papers), Bacteriophages and microbial interactions (3 papers), Sphingolipid Metabolism and Signaling (2 papers), RNA and protein synthesis mechanisms (2 papers) and Peroxisome Proliferator-Activated Receptors (1 paper). The work is most often cited by research in Genetics (170 citations), Molecular Biology (289 citations), Ecology (75 citations), Biotechnology (20 citations) and Oncology (55 citations). S Rubinchik has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Marvin Gold, Wendy Parris, Stephen Lowe, James S. Norris, Tsuyoshi Honda, Jian Dong, Alicja Bielawska, Mahvash Tavassoli, Christina Voelkel‐Johnson and Saeed Elojeimy. Their work appears in journals such as Gene Therapy, Journal of Biological Chemistry, Cancer Gene Therapy, Current Gene Therapy and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.